Response of intracranial metastases to erlotinib therapy.
Fekrazad
M Houman
MH
Section of Thoracic Oncology, University of New Mexico Cancer Research and Treatment Center, Albuquerque, NM, USA.
Ravindranathan
Meera
M
Jones
Dennie V
DV
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000556:secondary; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride